Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

LLY

Eli Lilly (LLY)

Eli Lilly and Co
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NYSE:LLY
日付受信時刻ニュースソース見出しコード企業名
2024/06/0422 : 00PR Newswire (US)Melissa Seymour to join Lilly as executive vice president of Global QualityNYSE:LLYEli Lilly and Co
2024/06/0407 : 30Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:LLYEli Lilly and Co
2024/06/0407 : 29Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:LLYEli Lilly and Co
2024/06/0405 : 15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
2024/06/0405 : 14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
2024/06/0405 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
2024/06/0121 : 00PR Newswire (US)Updated Data from the Phase 1/2 Study of Olomorasib in KRAS G12C-Mutant Advanced Solid Tumors Presented at the 2024 ASCO® Annual MeetingNYSE:LLYEli Lilly and Co
2024/06/0103 : 32Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:LLYEli Lilly and Co
2024/05/3105 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
2024/05/3005 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
2024/05/2919 : 00PR Newswire (US)Lilly, UNICEF expand support to help millions of young people at risk of noncommunicable diseasesNYSE:LLYEli Lilly and Co
2024/05/2905 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
2024/05/2823 : 00PR Newswire (US)Lilly to Participate in Goldman Sachs 45th Annual Global Healthcare ConferenceNYSE:LLYEli Lilly and Co
2024/05/2820 : 37IH Market NewsiPhone Sales Skyrocket in China, Nvidia Surges in Pre-Market Following xAI Fundraising, and More NewsNYSE:LLYEli Lilly and Co
2024/05/2505 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
2024/05/2504 : 13Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:LLYEli Lilly and Co
2024/05/2422 : 30PR Newswire (US)Lilly Increases Manufacturing Investment to $9 Billion at Newest Indiana Site to Boost API Production for Tirzepatide and Pipeline MedicinesNYSE:LLYEli Lilly and Co
2024/05/2406 : 00PR Newswire (US)Lilly Announces Details of Presentations at 2024 American Society of Clinical Oncology (ASCO) Annual MeetingNYSE:LLYEli Lilly and Co
2024/05/2405 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
2024/05/2305 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
2024/05/2205 : 24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
2024/05/2205 : 23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
2024/05/2205 : 21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
2024/05/2205 : 19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
2024/05/2205 : 18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
2024/05/2204 : 20Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:LLYEli Lilly and Co
2024/05/2121 : 00PR Newswire (US)More than one-half of patients with Crohn's disease treated with Lilly's mirikizumab achieved clinical remission at one year, including patients with previous biologic failureNYSE:LLYEli Lilly and Co
2024/05/2120 : 18IH Market NewsCalPERS to Oppose Exxon Mobil Directors; Microsoft Unveils Copilot+ PCs with AI Focus, and More NewsNYSE:LLYEli Lilly and Co
2024/05/1619 : 45PR Newswire (US)With Once-a-Week Dosing, Insulin Efsitora Alfa Delivers A1C Reduction and Safety Profile Consistent with Daily InsulinNYSE:LLYEli Lilly and Co
2024/05/1521 : 00PR Newswire (US)Alonzo Weems to Retire as Executive Vice President of Enterprise Risk Management and Chief Ethics and Compliance OfficerNYSE:LLYEli Lilly and Co
 Showing the most relevant articles for your search:NYSE:LLY